| Financial Year |
March 31 2023 |
| Monetary Funds |
226,605,940.55 |
| Held-for-trading Financial Assets |
1,223,933,098.82 |
| Notes Receivable |
226,946,130.18 |
| Accounts Receivable |
926,832,438.54 |
| Advances to Suppliers |
206,578,966.50 |
| Other Receivables |
32,043,959.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,601,281.28 |
| Inventories |
1,890,227,408.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
408,630,927.82 |
| Total Current Assets |
5,447,294,334.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
408,184,263.46 |
| Investment Properties |
12,296,268.76 |
| Fixed Assetes |
181,299,532.62 |
| Under-construction Projects |
30,846,546.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
55,945,811.73 |
| R&D expenses |
-- |
| Goodwill |
1,120,909.26 |
| Long-Term Deferred and Prepaid Expenses |
80,707.96 |
| Deferred Income Tax Assets |
42,576,259.92 |
| Other Non-Current Assets |
28,284,690.26 |
| Sub-Total of Non-Current Assets |
820,929,502.92 |
| Total Assets |
6,268,223,837.67 |
| Short-Term Loans |
11,130,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
244,371,531.04 |
| Accounts Received In Advance |
421,830.00 |
| Employee Compensation Payable |
21,051,885.79 |
| Taxes Payable |
39,174,387.38 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
17,770,244.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,388,882.64 |
| Other Current Liabilities |
138,116,798.02 |
| Sub-Total of Current Liabilities |
1,940,748,082.75 |
| Long-term Loans |
-- |
| Bonds Payable |
419,786,939.84 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,706,352.74 |
| Deferred Income Tax Liabilities |
15,068,526.76 |
| Other Non-Current Liabilities |
340,817,029.20 |
| Sub-Total of Non-Current Liabilities |
784,653,489.21 |
| Total Liabilities |
2,725,401,571.96 |
| Paid-In Capital(Or Share Stock) |
1,022,553,774.00 |
| Capital Surplus |
228,737,183.93 |
| Surplus Reserve |
300,522,057.11 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,746,444,708.56 |
| Minority Stockholder's Interest |
160,545,057.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,382,277,207.73 |
| Owner's Equity（Stockholder's Equity） |
3,542,822,265.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,268,223,837.67 |
